ONC01

Integrating the Latest Evidence on Immune Checkpoint Inhibitors Into the Management of Advanced Non-Small Cell Lung Cancer

Date

September 24, 2022

Explore related products in the following collection:

Oncology Congress

Speakers

Chris Prakash, MD

Medical Director, Texas Oncology - Paris

Mark G. Kris, MD

Attending Physician, Memorial Sloan Kettering Cancer Center

Related Products

Thumbnail for Management of Urothelial Carcinoma: Strategies for Addressing Health Disparities and Promoting Equitable Care

Management of Urothelial Carcinoma: Strategies for Addressing Health Disparities and Promoting Equitable Care

Thumbnail for Mitigating Disparities in Prostate Cancer Care: Strategies to Promote Equitable Care Across the Continuum

Mitigating Disparities in Prostate Cancer Care: Strategies to Promote Equitable Care Across the Continuum

Thumbnail for From Conference to Community: Advancing Equity in Multiple Myeloma Care and Treatment

From Conference to Community: Advancing Equity in Multiple Myeloma Care and Treatment

Thumbnail for Updates in the Diagnosis and Management of Chronic Lymphocytic Leukemia: Strategies for Addressing Disparities in Patient Care and Outcomes

Updates in the Diagnosis and Management of Chronic Lymphocytic Leukemia: Strategies for Addressing Disparities in Patient Care and Outcomes